SwedenBIO - branschorganisationen för life science

Dilafor AB

Dilafor develops pharmaceutical products from heparin derivatives with low anticoagulant activity. 
The company has a balanced product portfolio representing some highly promising ideas and innovations in obstetrics. 

All our drug development projects are based on Low Anticoagulant Heparin (LAH). Although standard heparin has numerous biological functions, its potential as a treatment for indications other than those currently approved is limited by its anticoagulative properties. Dilafor has produced several forms of LAH. 
One of them, Tafoxiparin is presently in development for the prevention and normalization of protracted labor. 

Kategorier: Pharma

Gå till Dilafor ABs hemsida